
Around thirty condom references, sold online and in pharmacies, are subject to recall due to the risk of breakage or perforations.
AI-generated summary
The DGCCRF has identified around thirty references to non-compliant condoms, some of which improperly bear the CE marking.
An alert on this type of product appeals to consumers. Around thirty non-compliant condom references, sold online and in pharmacies, are likely to lead to unwanted pregnancies or sexually transmitted infections, authorities warned on Friday August 21. According to the DGCCRF, in charge of combating fraud, around 1,000 boxes were sold, or more than 40,000 defective condoms, listed on the "consumer recall" site.
Most of these brands are marketed by Asian sellers. The alert also concerns two references of condoms having obtained CE marking (European conformity), and yet non-compliant due to a "risk of bursting" for one and "the presence of perforations" for the other. Some “260,000 units” were the subject of “recalls launched at the end of May and the beginning of August”.
Having just reached the age of majority, Paul and Sacha claim not to know the brands concerned, such as Friday Bae, Okamoto or Sagami. “We don’t know where it comes from, actually,” say the young men, who are not inspired by these condoms sold on large marketplaces like Amazon. “We think we're buying from a legitimate merchant with certification, but in reality we don't necessarily know what we're consuming,” they continue. “I would go directly to a pharmacy.”
Elisa will also go to the pharmacy because she also prefers not to take any risks with condoms. “Even in supermarkets, I am often a little reluctant. For me, health is extremely important, especially linked to sexuality,” she explains. “So, I will definitely go to a pharmacy and certainly not on the internet.”
And yet, some of these products have been sold on store and pharmacy shelves in recent months, according to authorities. For Bilal, it is theoretically a guarantee of quality: "I would not have checked the standards, etc. I would have seen it in the store, I would have said to myself 'it's good'." Except that certain products, particularly those sold online, did not meet standards and were not “CE” marked. Louis, a 39-year-old young father, underlines the importance of this standard: "Indeed, there are things that I tell myself that I will still check. If it comes from Amazon, from a site that I know, but if I do not know the seller particularly, I will at least look. Indeed, it is one of the minimum criteria when I do not know the brand and I do not trust it at the start."
In a pharmacy located not far away, Théodore Henric, assistant pharmacist, learned of the fraud repression alert, "it's sure shocking." For this professional, it is necessary to be extra vigilant, even with the CE standard. "It's a bit the same problem with eclipse glasses," he explains. "When you buy, there is necessarily the marking. But afterwards, you have two problems: you have the problem of the marking which is put when the organization itself received a file which was not great, and you also have the problem of counterfeiting."
Contacted by franceinfo, the Que Choisir Ensemble association asks consumers to be extremely vigilant and calls on platforms that sell products that do not comply with their responsibility.
Les vagues de chaleur en Europe ont causé plus de 30.000 décès excédentaires depuis fin mai, selon EuroMomo. L'Allemagne, la France et l'Espagne enregistrent les bilans les plus lourds, touchant particulièrement les personnes âgées de 75 ans et plus.
La DGCCRF et le ministère de la Santé alertent sur la vente de 40.000 préservatifs non conformes en France. Sans marquage CE ou présentant des risques de perforation, ils font courir des risques d'IST et de grossesses non désirées.

La Répression des fraudes et le ministère de la Santé alertent sur une trentaine de références de préservatifs non conformes vendus en ligne et en pharmacie, présentant des risques d'IST et de grossesses non désirées.

L'Assurance-maladie a mis à jour sa documentation sur l'encéphalomyélite myalgique, reconnaissant cette pathologie comme une maladie physique invalidante et non psychologique, une avancée saluée par les associations de patients.
Face aux critiques, le gouvernement français renonce au doublement immédiat du plafond annuel des franchises médicales et opte pour une indexation sur l'inflation depuis 2005, selon la ministre de la Santé Stéphanie Rist.

Moderna et Merck ont testé avec succès une thérapie combinant immunothérapie et vaccin personnalisé contre les rechutes de mélanome, réduisant significativement le risque de récidive chez plus de 1100 patients suivis.